(PAPR) may be used if fit-testing is not possible. â¢ Laboratories performing routine hematology and clinical chemistry studies. should handle specimens from potential pandemic/novel flu cases similarly. specimens containing other blood borne pathogens (e.g., hepatitis or HIV, see specific biosafety guidelines at.